Obstructive sleep apnea is a condition that disrupts rest, leading to symptoms such as daytime fatigue, brain fog and ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...

Heart disease is a leading cause of death worldwide, with men particularly susceptible to its often life-threatening ...

A recent study shows getting walking more may help prevent depressive symptoms. Tracking your steps may help you stay ...

Doctors at Memorial Health are sounding the alarm as they see a shocking rise in kids being treated for ingesting marijuana.

Doctors at Memorial Health are sounding the alarm as they see a shocking rise in kids being treated for ingesting marijuana.

The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.